老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ultragenyx Pharmaceutical Inc

14.30
-0.1000-0.69%
盤後：14.340.0426+0.30%19:48 EDT
成交量：325.37萬
成交額：4,658.17萬
市值：14.06億
市盈率：-2.45
高：14.70
開：14.43
低：14.13
收：14.40
52周最高：39.89
52周最低：13.81
股本：9,831.72萬
流通股本：8,071.56萬
量比：0.31
換手率：4.03%
股息：- -
股息率：- -
每股收益(TTM):-5.8279
每股收益(LYR):-5.8316
淨資產收益率：-608.47%
總資產收益率：-24.22%
市淨率：-4.83
市盈率(LYR):-2.45

資料載入中...

總覽公司新聞公告
2020/02/14

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

員工持股計劃

Securities to be offered to employees in employee benefit plans
2020/02/13

重要事件披露

Current report, items 2.02 and 9.01
2020/02/13

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/12

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/06

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/13

重要事件披露

Current report, items 2.02, 7.01, 8.01, and 9.01
2020/01/09

重要事件披露

Current report, items 7.01, 8.01, and 9.01
2020/01/08

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/12/18

重要事件披露

Current report, item 1.01
2019/11/25

重要事件披露

Current report, items 5.02 and 9.01
2019/11/06

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/11/05

重要事件披露

Current report, items 2.02 and 9.01
2019/10/10

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/09/04

重要事件披露

Current report, items 7.01, 8.01, and 9.01
2019/08/14

重要事件披露

Current report, items 7.01, 8.01, and 9.01
2019/08/02

季度報告

Quarterly report [Sections 13 or 15(d)]
更多